Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
Makaleler > Tam Makale · 2019
Yazarlar: Mike Becker, Nicole Graf, Rafael Sauter, Yannick Allanore, John Curram, Christopher P. Denton, Dinesh Khanna, Janethe de Oliveira Pena, Janet E. Pope, Oliver Distler, Marco Matucci-Cerinic, Serena Guiducci, Ulrich Walker, Veronika Jaeger, Bettina Bannert, Giovanni Lapadula, Radim Becvarare, Maurizio Cutolo, Gabriele Valentini, Elise Siegert, Simona Rednic, Yannick Allanore, C. Montecucco, Patricia E. Carreira, Srdan Novak, Laszlo Czirjak, Cecilia Varju, Carlo Chizzolini, Daniela Allai, Eugene J. Kucharz, Franco Cozzi, Blaz Rozman, Carmel Mallia, Armando Gabrielli, Dominique Farge Bancel, Paolo Airo, Roger Hesselstrand, Duska Martinovic, Alexandra Balbir-Gurman, Yolanda Braun-Moscovici, Nicolas Hunzelmann, Raffaele Pellerito, Paola Caramaschi, Carol Black, Nemanja Damjanov, Joerg Henes, Vera Ortiz Santamaria, Stefan Heitmann, Matthias Seidel, Jose Antonio Pereira Da Silva, Bojana Stamenkovic, Carlo Francesco Selmi, Mohammed Tikly, Lev N. Denisov, Ulf Mueller-Ladner, Merete Engelhart, Eric Hachulla, Valeria Riccieri, Ruxandra Maria Ionescu, Carina Mihai, Cord Sunderkoetter, Annegret Kuhn, Georg Schett, Joerg Distler, Pierluigi Meroni, Francesca Ingegnoli, Luc Mouthon, Filip De Keyser, Vanessa Smith, Francesco Paolo Cantatore, Ada Corrado, Susanne Ullman, Line Iversen, Maria Rosa Pozzi, Kilian Eyerich, Ruediger Hein, Elisabeth Knott, Piotr Wiland, Magdalena Szmyrka-Kaczmarek, Renata Sokolik, Ewa Morgiel, Marta Madej, Juan Jose Alegre-Sancho, Brigitte Krummel-Lorenz, Petra Saar, Martin Aringer, Claudia Guenther, Erler Anne, Rene Westhovens, Ellen De langhe, Jan Lenaerts, Branimir Anic, Marko Baresic, Miroslav Mayer, Maria Uprus, Kati Otsa, Sule Yavuz, Sebastiao Cezar Radominski, Carolina de Souza Mueller, Valderilio Feijo Azevedo, Sergei Popa, Simon Stebbings, Douglas Veale, Mengtao Li, Fahrettin OKSEL, Figen YARGUCU ZİHNİ, Algirdas Venalis, Eduardo Kerzberg
ANNALS OF THE RHEUMATIC DISEASES, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2019, cilt 78, ss 1242-1248
DOI: 10.1136/annrheumdis-2019-215145
Özet
Objectives Mortality and worsening of organ function are desirable endpoints for clinical trials in systemic sclerosis (SSc). The aim of this study was to identify factors that allow enrichment of patients with these endpoints, in a population of patients from the European Scleroderma Trials and Research group database.